BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Mark F McCarty, Aaron Lerner. Perspective: Prospects for Nutraceutical Support of Intestinal Barrier FunctionAdvances in Nutrition 2020;  doi: 10.1093/advances/nmaa139
2
Raphael Alhadeff, Arieh Warshel. A free‐energy landscape for the glucagon‐like peptide 1 receptor GLP1RProteins: Structure, Function, and Bioinformatics 2020; 88(1): 127 doi: 10.1002/prot.25777
3
Yajie Dong, Qingguo Lv, Sheyu Li, Yuan Wu, Ling Li, Juan Li, Fang Zhang, Xin Sun, Nanwei Tong. Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2017; 41(3): 284 doi: 10.1016/j.clinre.2016.11.009
4
Haaglim Cho, JungIn Um, Ji-Hyung Lee, Woong-Hee Kim, Wan Seok Kang, So Hun Kim, Hyung-Ho Ha, Yong-Chul Kim, Young-Keun Ahn, Da-Woon Jung, Darren R. Williams. ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetesScientific Reports 2017; 7(1) doi: 10.1038/srep44186
5
Olusola F. Onoviran, Dongming Li, Sarah Toombs Smith, Mukaila A. Raji. Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitusTherapeutic Advances in Chronic Disease 2019; 10: 204062231986269 doi: 10.1177/2040622319862691
6
Sanjay Kalra, Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee, Banshi Saboo, Ganapathi Bantwal, Saptarshi Bhattacharya, Gagan Priya, Manoj Chawla, Kiraninder Brar, Syed Abbas Raza, Azizul Hasan Aamir, Dina Shrestha, Noel Somasundaram, Prasad Katulanda, Faria Afsana, Shahjada Selim, Mohammad Wali Naseri, Ali Latheef, Manilka Sumanatilleke. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task ForceDiabetes Therapy 2019; 10(5): 1645 doi: 10.1007/s13300-019-0669-4
7
Ali Jazayeri, Mathieu Rappas, Alastair J. H. Brown, James Kean, James C. Errey, Nathan J. Robertson, Cédric Fiez-Vandal, Stephen P. Andrews, Miles Congreve, Andrea Bortolato, Jonathan S. Mason, Asma H. Baig, Iryna Teobald, Andrew S. Doré, Malcolm Weir, Robert M. Cooke, Fiona H. Marshall. Crystal structure of the GLP-1 receptor bound to a peptide agonistNature 2017; 546(7657): 254 doi: 10.1038/nature22800
8
Elizabeth G. Mietlicki-Baase, Lauren E. McGrath, Kieran Koch-Laskowski, Joanna Krawczyk, Tram Pham, Rinzin Lhamo, David J. Reiner, Matthew R. Hayes. Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balancePhysiology & Behavior 2017; 173: 9 doi: 10.1016/j.physbeh.2017.01.038
9
Hidetaka Hamasaki. Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment?World Journal of Diabetes 2018; 9(8): 138-140 doi: 10.4239/wjd.v9.i8.138
10
Lei Zhang, Shi-Tao Zhang, Yan-Chun Yin, Shu Xing, Wan-Nan Li, Xue-Qi Fu. Hypoglycemic effect and mechanism of isoquercitrin as an inhibitor of dipeptidyl peptidase-4 in type 2 diabetic miceRSC Advances 2018; 8(27): 14967 doi: 10.1039/C8RA00675J